TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04200989

Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“Lack of funding”

The sponsor’s own words in the registry.

Life of this trial

20192020202120222023Registered2019-12-12Planned start2021-03-01 (planned)Withdrawn (as of)2022-11-22

Vital statistics

Status
Withdrawn
Phase
Phase 1, Phase 2
Sponsor
Scripps Health
Sponsor type
University, hospital or other
Conditions
Food Allergy Peanut
Interventions
Peanut allergen
Participants
0
Sites
1
Countries
United States

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.